Olodaterol HCl, the hydrochloride salt of Olodaterol (BI-1744; BI1744; STRIVERDI RESPIMAT), is a ultra-long acting β-adrenergic receptor agonist approved in 2014 as an inhalation for the treatment of patients with chronic obstructive pulmonary disease (COPD).

纯度：≥98%

CAS：869477-96-3